InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by Farrow Jeffrey S, Chief Financial Officer. Director active across 1 companies, notably Global Blood Therapeutics, Inc.. In total, 9 filings have been published. Regulator: SEC (Form 4). The full history is free.
Declarations9 total
2,763 shares
Common Stock
SEC:0000899243-22-009239:0·
9,020 shares
Common Stock
SEC:0000899243-22-004639·
9,020 shares
Common Stock
SEC:0000899243-22-004639:0·
9,020 shares
Common Stock
SEC:0000899243-21-037668·
9,020 shares
Common Stock
SEC:0000899243-21-037668:0·
2,762 shares
Common Stock
SEC:0000899243-21-035221·
2,762 shares
Common Stock
SEC:0000899243-21-035221:0·
9,020 shares
Common Stock
SEC:0000899243-21-031353·
9,020 shares
Common Stock
SEC:0000899243-21-031353:0·
9 of 9 declarations
About Farrow Jeffrey S
Jeffrey S. Farrow is the Chief Financial Officer of Global Blood Therapeutics, Inc. In this role, he oversees the financial management of the company, including financial planning, risk management, and financial reporting. Farrow plays a crucial role in the company's financial strategy, contributing to informed decision-making to support growth and profitability. His experience in finance is a valuable asset to the organization.
